{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:02:33Z","timestamp":1794344553287,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008977","name":"Universit\u00e4t Ulm","doi-asserted-by":"publisher","award":["514808265"],"award-info":[{"award-number":["514808265"]}],"id":[{"id":"10.13039\/501100008977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neo.2024.101086","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T16:10:56Z","timestamp":1732723856000},"page":"101086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["5-Aza-2\u2032-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cells"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1806-5932","authenticated-orcid":false,"given":"Adrian","family":"Fehn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6766-4758","authenticated-orcid":false,"given":"Adrian","family":"von Witzleben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla","family":"Grages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8072-757X","authenticated-orcid":false,"given":"Tsima Abou","family":"Kors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Ezi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika C.","family":"Betzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1065-8709","authenticated-orcid":false,"given":"Patrick J.","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Nicole","family":"Theodoraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6732-7137","authenticated-orcid":false,"given":"Simon","family":"Laban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2024.101086_bib0001","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.neo.2024.101086_bib0002","doi-asserted-by":"crossref","first-page":"S1310","DOI":"10.1016\/j.annonc.2021.08.2113","article-title":"LBA36 Nivolumab (N) + ipilimumab (I) vs EXTREME as first-line (1L) treatment (tx) for recurrent\/metastatic squamous cell carcinoma of the head and neck (R\/M SCCHN): Final results of CheckMate 651","volume":"32","author":"Argiris","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neo.2024.101086_bib0003","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1074-7613(01)00227-8","article-title":"A Critical Role for Dnmt1 and DNA Methylation in T Cell Development, Function, and Survival","volume":"15","author":"Lee","year":"2001","journal-title":"Immunity."},{"key":"10.1016\/j.neo.2024.101086_bib0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2024.101086_bib0005","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1200\/JCO.2010.30.9245","volume":"29","author":"L\u00fcbbert","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2024.101086_bib0006","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.23607","article-title":"Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine","volume":"123","author":"Stresemann","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neo.2024.101086_bib0007","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neo.2024.101086_bib0008","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/1078-0432.CCR-17-1792","article-title":"NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome","volume":"24","author":"Griffiths","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2024.101086_bib0009","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ijc.28752","article-title":"Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer","volume":"135","author":"Laban","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neo.2024.101086_bib0010","doi-asserted-by":"crossref","first-page":"14719","DOI":"10.18632\/oncotarget.14830","article-title":"MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy","volume":"8","author":"Laban","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.neo.2024.101086_bib0011","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1158\/1078-0432.CCR-19-1490","article-title":"Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients","volume":"25","author":"Laban","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2024.101086_bib0012","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.4049\/jimmunol.1502643","article-title":"Genetic and epigenetic regulation of PD-1 expression","volume":"196","author":"Bally","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.neo.2024.101086_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000552","article-title":"LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma","volume":"8","author":"Kl\u00fcmper","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.neo.2024.101086_bib0014","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.02151","article-title":"Addition of Low-Dose Decitabine to Anti\u2013PD-1 Antibody Camrelizumab in Relapsed\/Refractory Classical Hodgkin Lymphoma","author":"Nie","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2024.101086_bib0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","article-title":"De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation","volume":"170","author":"Ghoneim","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neo.2024.101086_bib0016","article-title":"Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy","volume":"32","author":"Russo","year":"2024","journal-title":"Mol. Therapy Oncol."},{"key":"10.1016\/j.neo.2024.101086_bib0017","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41467-020-20696-x","article-title":"Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2024.101086_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005177","article-title":"CD39 Expression Identifies Terminally Exhausted CD8+ T Cells","volume":"11","author":"Gupta","year":"2015","journal-title":"PLOS Pathogens"},{"key":"10.1016\/j.neo.2024.101086_bib0019","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1158\/2326-6066.CIR-20-0270","article-title":"CD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human Cancer","volume":"8","author":"Kortekaas","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.neo.2024.101086_bib0020","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/eji.201142347","article-title":"Phenotypic and functional characteristics of ATP-hydrolysing CD4+CD39+ FOXP3+ and CD4+CD39+ FOXP3neg T-cell subsets in patients with cancer","volume":"42","author":"Schuler","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neo.2024.101086_bib0021","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1158\/0008-5472.CAN-15-2125","article-title":"Combining Epigenetic and Immunotherapy to Combat Cancer","volume":"76","author":"Chiappinelli","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2024.101086_bib0022","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/jcm.33.4.901-905.1995","article-title":"Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes","volume":"33","author":"Jacobs","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.neo.2024.101086_bib0023","doi-asserted-by":"crossref","first-page":"12088","DOI":"10.1038\/s41598-018-30623-2","article-title":"Strong increase in the autofluorescence of cells signals struggle for survival","volume":"8","author":"Surre","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neo.2024.101086_bib0024","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.2020008477","article-title":"Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia","volume":"138","author":"Han","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.neo.2024.101086_bib0025","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1073\/pnas.0707140104","article-title":"Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming","volume":"105","author":"Atanackovic","year":"2008","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.neo.2024.101086_bib0026","doi-asserted-by":"crossref","first-page":"E590","DOI":"10.1002\/ijc.29118","article-title":"NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus","volume":"136","author":"Chen","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neo.2024.101086_bib0027","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","article-title":"An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma","volume":"585","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.neo.2024.101086_bib0028","first-page":"84","article-title":"Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen","volume":"37","author":"Wada","year":"2014","journal-title":"J. Immun."},{"key":"10.1016\/j.neo.2024.101086_bib0029","doi-asserted-by":"crossref","unstructured":"Zandberg, D.P. et al. A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent\/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN. Cancer immunology, immunotherapy: CII (2014).","DOI":"10.1007\/s00262-014-1640-x"},{"key":"10.1016\/j.neo.2024.101086_bib0030","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.molcel.2021.01.038","article-title":"DNA hypomethylating agents increase activation and cytolytic activity of CD8+ T cells","volume":"81","author":"Yau","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neo.2024.101086_bib0031","doi-asserted-by":"crossref","first-page":"22900","DOI":"10.1074\/jbc.M111.312785","article-title":"De Novo DNA Methylation Is Required to Restrict T Helper Lineage Plasticity *","volume":"287","author":"Thomas","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neo.2024.101086_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197151","article-title":"CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes","volume":"13","author":"Raczkowski","year":"2018","journal-title":"PLoS. One"},{"key":"10.1016\/j.neo.2024.101086_bib0033","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.186.9.1407","article-title":"Phenotypic and functional separation of memory and effector human CD8+ T cells","volume":"186","author":"Hamann","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neo.2024.101086_bib0034","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2567.2004.01974.x","article-title":"K. CD27\u2212 CD4+ memory T cells define a differentiated memory population at both the functional and transcriptional levels","volume":"113","author":"Schi\u00f6tt","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.neo.2024.101086_bib0035","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1038\/s41467-018-05072-0","article-title":"Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors","volume":"9","author":"Duhen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2024.101086_bib0036","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neo.2024.101086_bib0037","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13059-019-1921-y","article-title":"Distinct epigenetic features of tumor-reactive CD8+ T cells in colorectal cancer patients revealed by genome-wide DNA methylation analysis","volume":"21","author":"Yang","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.neo.2024.101086_bib0038","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.4049\/jimmunol.165.9.5035","article-title":"Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4+ T Cells1","volume":"165","author":"McAdam","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.neo.2024.101086_bib0039","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.leukres.2012.03.026","article-title":"Azacitidine differentially affects CD4(pos) T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromes","volume":"36","author":"Bontkes","year":"2012","journal-title":"Leuk. Res."},{"key":"10.1016\/j.neo.2024.101086_bib0040","doi-asserted-by":"crossref","first-page":"e71029","DOI":"10.1371\/journal.pone.0071029","article-title":"STAT3 signaling induces the differentiation of human ICOS(+) CD4 T cells helping B lymphocytes","volume":"8","author":"Ysebrant de Lendonck","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.neo.2024.101086_bib0041","first-page":"1896","article-title":"STAT3 signaling pathway is involved in decitabine induced biological phenotype regulation of acute myeloid leukemia cells","volume":"7","author":"Zhu","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.neo.2024.101086_bib0042","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.31557\/APJCP.2021.22.7.2089","volume":"22","author":"Sanaei","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.neo.2024.101086_bib0043","article-title":"Suppressor of Cytokine Signaling (SOCS) Genes Are Silenced by DNA Hypermethylation and Histone Deacetylation and Regulate Response to Radiotherapy in Cervical Cancer Cells","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS. One"},{"key":"10.1016\/j.neo.2024.101086_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005349","article-title":"TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection","volume":"12","author":"Chew","year":"2016","journal-title":"PLOS Pathogens"},{"key":"10.1016\/j.neo.2024.101086_bib0045","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.celrep.2016.01.002","article-title":"Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals","volume":"14","author":"Fang","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.neo.2024.101086_bib0046","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.neo.2024.101086_bib0047","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1101\/gad.473408","article-title":"Regulation of alternative polyadenylation by genomic imprinting","volume":"22","author":"Wood","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.neo.2024.101086_bib0048","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1534\/genetics.106.069484","article-title":"Transcriptional Interferences in cis Natural Antisense Transcripts of Humans and Mice","volume":"176","author":"Osato","year":"2007","journal-title":"Genetics"},{"key":"10.1016\/j.neo.2024.101086_bib0049","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.immuni.2019.01.003","article-title":"The Histone Methyltransferase SETDB1 Controls T Helper Cell Lineage Integrity by Repressing Endogenous Retroviruses","volume":"50","author":"Adoue","year":"2019","journal-title":"Immunity."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624001271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624001271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T12:55:23Z","timestamp":1734353723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558624001271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":49,"alternative-id":["S1476558624001271"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2024.101086","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Aza-2\u2032-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cells","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2024.101086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101086"}}